COVID-19 Collection

Journal article

Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial

Publication status:: Accepted

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Haynes, R., Landray, M., Staplin, N., Spata, E., Peto, L., Knight, M., Mafham, M., Emberson, J., & Horby, P. (2023). Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial. Lancet Child and Adolescent Health.

MLA Style

Haynes, R, et al. “Methylprednisolone, Intravenous Immunoglobulin, Tocilizimab or Anakinra for Children with Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS CoV-2 (PIMS-TS, MIS-C) – Report from a Randomised, Controlled, Open-Label, Platform Trial.” Lancet Child and Adolescent Health, 2023.

Chicago Style

Haynes, R, M Landray, N Staplin, et al. 2023. “Methylprednisolone, Intravenous Immunoglobulin, Tocilizimab or Anakinra for Children with Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS CoV-2 (PIMS-TS, MIS-C) – Report from a Randomised, Controlled, Open-Label, Platform Trial.” Lancet Child and Adolescent Health.
Print

Authors

+ Haynes, R More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author
ORCID:: 0000-0002-1179-0023

+ Landray, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Role:: Author

+ Staplin, N More by this author

Role:: Author

+ Spata, E More by this author

Role:: Author

+ Peto, L More by this author

Role:: Author

More authors...

Contributors

+ RECOVERY Collaborative Group

Role:: Contributor

+ Medical Research Council More from this funder

Grant:: MC_PC_19056

Publisher:: Elsevier
Journal:: Lancet Child and Adolescent Health More from this journal
Publication date:: 2023-11-20
Acceptance date:: 2023-11-17
EISSN:: 2352-4642

Language:: English
Keywords:: FFR
Pubs id:: 1568775
Local pid:: pubs:1568775
Deposit date:: 2023-11-20
ARK identifier:: ark:/29072/ora_6ad9d5615a614a0fb280843027b19b83

Terms of use

Copyright date:: 2023
Notes:: This article has been accepted for publication in Lancet Child and Adolescent Health

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP